BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14526145)

  • 1. Synergistic activity of gamma-linolenic acid and cytotoxic drugs against pancreatic adenocarcinoma cell lines.
    Whitehouse PA; Cooper AJ; Johnson CD
    Pancreatology; 2003; 3(5):367-73; discussion 373-4. PubMed ID: 14526145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.
    Singla S; Pippin JA; Drebin JA
    Oncol Rep; 2012 Dec; 28(6):2211-6. PubMed ID: 23007710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
    Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
    J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Park SJ; Kim H; Shin K; Hong TH; Suh JH; Lee MA
    BMC Cancer; 2021 Nov; 21(1):1176. PubMed ID: 34732161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells.
    Menéndez JA; Ropero S; del Barbacid MM; Montero S; Solanas M; Escrich E; Cortés-Funes H; Colomer R
    Breast Cancer Res Treat; 2002 Apr; 72(3):203-19. PubMed ID: 12058962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2.
    Bellone G; Carbone A; Busso V; Scirelli T; Buffolino A; Smirne C; Novarino A; Bertetto O; Tosetti L; Emanuelli G
    Cancer Biol Ther; 2006 Oct; 5(10):1294-303. PubMed ID: 16929163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
    DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
    J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer.
    Eisenberg DP; Adusumilli PS; Hendershott KJ; Yu Z; Mullerad M; Chan MK; Chou TC; Fong Y
    J Gastrointest Surg; 2005 Nov; 9(8):1068-77; discussion 1077-9. PubMed ID: 16269377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.
    Damaraju VL; Bouffard DY; Wong CK; Clarke ML; Mackey JR; Leblond L; Cass CE; Grey M; Gourdeau H
    BMC Cancer; 2007 Jul; 7():121. PubMed ID: 17608948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures.
    Daunys S; Matulis D; Petrikaitė V
    Sci Rep; 2019 Nov; 9(1):16177. PubMed ID: 31700053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein.
    El-Mahdy HA; El-Husseiny AA; Kandil YI; Gamal El-Din AM
    Life Sci; 2020 Dec; 262():118518. PubMed ID: 33011221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer.
    Daylami R; Muilenburg DJ; Virudachalam S; Bold RJ
    J Exp Clin Cancer Res; 2014 Dec; 33(1):102. PubMed ID: 25499121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells.
    Smith PL; Yogaratnam Y; Samad M; Kasow S; Dalgleish AG
    Clin Transl Oncol; 2021 Jan; 23(1):110-121. PubMed ID: 32661823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
    Bader Y; Hartmann J; Horvath Z; Saiko P; Grusch M; Madlener S; Maier S; Oehler L; Fritzer-Szekeres M; Heller N; Alken RG; Krupitza G; Szekeres T
    Cancer Lett; 2008 Feb; 259(2):231-9. PubMed ID: 18023527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro evaluation of potentially effective gemcitabine combination therapy for exocrine pancreatic carcinoma].
    Kreil A; Bauer J; Scheithauer W
    Acta Med Austriaca; 1999; 26(3):93-100. PubMed ID: 10520377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ; Liu HL
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trial.
    McAllister F; Pineda DM; Jimbo M; Lal S; Burkhart RA; Moughan J; Winter KA; Abdelmohsen K; Gorospe M; Acosta Ade J; Lankapalli RH; Winter JM; Yeo CJ; Witkiewicz AK; Iacobuzio-Donahue CA; Laheru D; Brody JR
    Cancer Biol Ther; 2014 Jun; 15(6):688-98. PubMed ID: 24618665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
    Shi X; Liu S; Kleeff J; Friess H; Büchler MW
    Oncology; 2002; 62(4):354-62. PubMed ID: 12138244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
    Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
    Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma.
    Shimamura T; Royal RE; Kioi M; Nakajima A; Husain SR; Puri RK
    Cancer Res; 2007 Oct; 67(20):9903-12. PubMed ID: 17942922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.